Kambiz Yazdi
Stock Analyst at BTIG
(4.54)
# 267
Out of 5,113 analysts
16
Total ratings
68.75%
Success rate
28.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $42.60 | +36.15% | 3 | Jan 14, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $507 → $843 | $294.04 | +186.70% | 5 | Dec 29, 2025 | |
| RAPP Rapport Therapeutics | Reiterates: Buy | $47 | $26.45 | +77.69% | 2 | Dec 8, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $40 | $33.86 | +18.13% | 1 | Nov 19, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $15.65 | +46.96% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $26.32 | -27.81% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $15.45 | -2.91% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.17 | +327.35% | 1 | Apr 12, 2024 |
Sionna Therapeutics
Jan 14, 2026
Reiterates: Buy
Price Target: $58
Current: $42.60
Upside: +36.15%
Praxis Precision Medicines
Dec 29, 2025
Maintains: Buy
Price Target: $507 → $843
Current: $294.04
Upside: +186.70%
Rapport Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $47
Current: $26.45
Upside: +77.69%
vTv Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $40
Current: $33.86
Upside: +18.13%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $15.65
Upside: +46.96%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $26.32
Upside: -27.81%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $15.45
Upside: -2.91%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.17
Upside: +327.35%